[This corrects the article DOI: 10.1371/journal.pone.0103482.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162513PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0232166PLOS

Publication Analysis

Top Keywords

correction galectin-3
4
galectin-3 marker
4
marker potential
4
potential therapeutic
4
therapeutic target
4
target breast
4
breast cancer
4
cancer [this
4
[this corrects
4
corrects article
4

Similar Publications

An annotated high-content fluorescence microscopy dataset with EGFP-Galectin-3-stained cells and manually labelled outlines.

Data Brief

February 2025

Cell Death, Lysosomes and Artificial Intelligence Group, Department of Experimental Medical Science, Faculty of Medicine, Lund University, BMC D10, 22184 Lund, Sweden.

Many forms of bioimage analysis involve the detection of objects and their outlines. In the context of microscopy-based high-throughput drug and genomic screening and even in smaller scale microscopy experiments, the objects that most often need to be detected are cells. In order to develop and benchmark algorithms and neural networks that can perform this task, high-quality datasets with annotated cell outlines are needed.

View Article and Find Full Text PDF

SMURF1 mediates damaged lysosomal homeostasis by ubiquitinating PPP3CB to promote the activation of TFEB.

Autophagy

October 2024

Department of General Surgery, Aerospace Center Hospital, School of Life Science, Beijing Institute of Technology, Beijing, China.

The calcium-activated phosphatase PPP3/calcineurin dephosphorylates TFEB (transcription factor EB) to trigger its nuclear translocation and the activation of macroautophagic/autophagic targets. However, the detailed molecular mechanism regulating TFEB activation remains poorly understood. Here, we highlighted the importance of SMURF1 (SMAD specific E3 ubiquitin protein ligase 1) in the activation of TFEB for lysosomal homeostasis.

View Article and Find Full Text PDF

Pediatric reference values of NT-proBNP and Galectin-3 based on a French cohort.

Clin Chim Acta

January 2025

Department of Pediatric Cardiac Surgery, AP-HP, Necker-Enfants Malades Hospital, Paris, France; Pediatric Cardiology Unit, Women and Child Department, Lausanne University Hospital, Lausanne, Switzerland. Electronic address:

Background: In pediatric cardiology, the fact that some new biomarkers have assay-specific normal values has to be considered for correct clinical decisions. The current study aimed to provide age-adjusted normative values for NT-proBNP and Galectin-3 using the Abbott immunoassay system from a prospective French pediatric cohort sera collection and to validate our data for NT-proBNP on a second retrospective cohort.

Methods: We analyzed 283 consecutive samples for NT-proBNP and 140 samples for Galectin-3 collected from apparently healthy children (0-18 years) with outpatient treatment at our institution (Hôpital Necker-Enfants malades, Paris, France) during 24 months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!